Tat RNA silencing suppressor activity contributes to perturbation of lymphocyte miRNA by HIV-1.
about
HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodiesMicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic ConsiderationsMicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapyHIV-1 Vpr redirects host ubiquitination pathway.RNAi in the regulation of mammalian viral infections.MicroRNA-29 family expression and its relation to antiviral immune response and viro-immunological markers in HIV-1-infected patientsNon-coding RNAs and HIV: viral manipulation of host dark matter to shape the cellular environment.Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivoConstructing an integrated genetic and epigenetic cellular network for whole cellular mechanism using high-throughput next-generation sequencing data.Cellular RNA helicases and HIV-1: insights from genome-wide, proteomic, and molecular studiesImpact of cellular autophagy on viruses: Insights from hepatitis B virus and human retroviruses.MicroRNA-mediated restriction of HIV-1 in resting CD4+ T cells and monocytes.MicroRNAs and HIV-1: complex interactions.Tombusvirus P19 RNA silencing suppressor (RSS) activity in mammalian cells correlates with charged amino acids that contribute to direct RNA-binding.Host restriction factors in retroviral infection: promises in virus-host interaction.Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.HIV-1 transcription and latency: an update.Reconstructing the temporal progression of HIV-1 immune response pathways.Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat ProteinDeployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic developmentHIV-1 Tat-shortened neurite outgrowth through regulation of microRNA-132 and its target gene expression.Hepatitis C Virus and HIV Type 1 Co-Infection.Antiviral effects of human microRNAs and conservation of their target sites.MicroRNAs and their potential involvement in HIV infectionHigh-throughput sequencing identifies HIV-1-replication- and latency-related miRNAs in CD4+ T cell lines.MicroRNAs, HIV and HCV: a complex relation towards pathology.HIV/neuroAIDS biomarkers.HIV-1 Tat C modulates NOX2 and NOX4 expressions through miR-17 in a human microglial cell line.HLA-G/C, miRNAs, and their role in HIV infection and replication.MicroRNAs in HIV-1 infection: an integration of viral and cellular interaction at the genomic level.Molecular Control of HIV and SIV Latency.
P2860
Q24297395-592526F5-A8FC-4249-860A-826E8D4FD7B5Q26773183-D47C9AB3-698F-48D4-B83D-3C6BE301F32EQ27015778-A87B199E-76EE-469D-A707-413DA73387DBQ34059218-B0EF2D4C-F7EA-472F-BEED-1D6EC04672ABQ34317333-A8511741-824C-4E55-B1B8-02BEAF5E0ACEQ35108559-7E96AD18-DB50-4E66-A75E-60C345F2BAF4Q35219072-CB21B22B-49DF-47BE-B294-843E2BCAAD1EQ35295003-9775050D-57F9-4002-A5ED-548645F7E4ADQ35929292-46652A7F-F271-408B-AF18-039787E7088AQ36384968-09BA6645-9ABE-428B-8391-70F16532BF45Q36389858-BB7B6879-954F-4E61-A811-F400D7FB9CE8Q36404157-F5AA2F72-C8B8-4A01-9190-FFA3D8789A77Q36435987-E9FC5B43-B8CF-4CFE-B025-1F30B7A396E4Q36499148-3D2003F5-F0DC-4D36-AE79-DC5F72159CC2Q36548179-68F7605D-A417-4AC9-9551-E3EB97BA7E0BQ36576661-7A9D67A8-5176-41E1-BB67-E829A2343B3AQ36976156-2BF112B3-AF90-499F-A5ED-733BFB11E427Q37005470-7383B60A-5DFC-48D9-97B3-E11426063BBCQ37120233-B98DD853-3A40-4235-815F-7BB8FE2A6A2FQ37127522-A25C02A6-5A63-47E6-8450-7A0B4489A1DDQ37260505-6CA02234-C115-4CB4-A99E-1B92B44A932CQ37481988-9F326BA3-6082-4039-AA40-917F0E7E6B2CQ37904339-0CA09077-8A1C-4A22-AF75-1D99E4720F97Q37921416-838C352B-E279-4EBE-AF22-077065DF9260Q38711900-BBE22F81-CAD8-4CFA-A03C-5836EE4140DCQ38802349-FAE5F2C4-7D53-4B33-8759-BC0F179F4EA4Q38809646-69204A23-6893-44B4-BD70-D5B8659F320EQ38963813-173F1747-E91D-4D0A-9C9C-27AEB3B76BC4Q42284873-1186D1BD-F8E0-4BB4-88D7-F5FBEE500812Q42321099-678B35C9-91C3-439E-9D96-713193E0161FQ47600043-54790AF1-F57E-48BF-A1F8-89DE4B8602D4
P2860
Tat RNA silencing suppressor activity contributes to perturbation of lymphocyte miRNA by HIV-1.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Tat RNA silencing suppressor a ...... of lymphocyte miRNA by HIV-1.
@en
type
label
Tat RNA silencing suppressor a ...... of lymphocyte miRNA by HIV-1.
@en
prefLabel
Tat RNA silencing suppressor a ...... of lymphocyte miRNA by HIV-1.
@en
P2093
P2860
P356
P1433
P1476
Tat RNA silencing suppressor a ...... n of lymphocyte miRNA by HIV-1
@en
P2093
Amy M Hayes
Shuiming Qian
P2860
P2888
P356
10.1186/1742-4690-8-36
P577
2011-05-13T00:00:00Z
P5875
P6179
1051055286